Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shailesh R Shah

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Bioorganic Chemistry|November 14, 2019
Anticancer, antimicrobial activities of quinoline based hydrazone analogues: Synthesis, characterization and molecular dockingKanubhai D Katariya, Shailesh R Shah, Dushyanth Reddy
Bioorganic & Medicinal Chemistry Letters|March 29, 2014
Design, synthesis and biological evaluation of novel aminomethyl-piperidones based DPP-IV inhibitorsPradip Jadav, Rajesh Bahekar, Shailesh R Shah, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|October 4, 2012
Peptidomimetics as potent and selective PTP1B inhibitorsDipam Patel, Mukul Jain, Shailesh R Shah, et al.
Bioorganic & Medicinal Chemistry Letters|April 17, 2012
Long-acting peptidomimetics based DPP-IV inhibitorsPradip Jadav, Rajesh Bahekar, Shailesh R Shah, et al.
Bioorganic & Medicinal Chemistry Letters|December 23, 2011
Discovery of potent, selective and orally bioavailable triaryl-sulfonamide based PTP1B inhibitorsDipam Patel, Mukul Jain, Shailesh R Shah, et al.
ACS Medicinal Chemistry Letters|January 19, 2023
In the Quest for Potent and Selective Malic Enzyme 3 Inhibitors for the Treatment of Pancreatic Ductal AdenocarcinomaGaurav Sheth, Shailesh R Shah, Prabal Sengupta, et al.
Bioorganic & Medicinal Chemistry|January 11, 2011
Effect of structurally constrained oxime-ether linker on PPAR subtype selectivity: Discovery of a novel and potent series of PPAR-pan agonistsPankaj Makadia, Shailesh R Shah, Harikishore Pingali, et al.
Chemmedchem|September 14, 2025
Strategic Design and Development of Indole-Based Compounds as Potent Malic Enzyme 3 Inhibitors for Pancreatic Tumor TherapyGaurav Sheth, Shailesh R Shah, Prabal Sengupta, et al.
Bioorganic & Medicinal Chemistry|February 21, 2021
Discovery of a potent G-protein-coupled receptor 119 agonist for the treatment of type 2 diabetesSuresh Pola, Shailesh R Shah, Harikishore Pingali, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2011
Modulation of PPAR subtype selectivity. Part 2: Transforming PPARα/γ dual agonist into α selective PPAR agonist through bioisosteric modificationPandurang Zaware, Shailesh R Shah, Harikishore Pingali, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Bioorganic Chemistry|November 14, 2019
Anticancer, antimicrobial activities of quinoline based hydrazone analogues: Synthesis, characterization and molecular dockingKanubhai D Katariya, Shailesh R Shah, Dushyanth Reddy
Bioorganic & Medicinal Chemistry Letters|March 29, 2014
Design, synthesis and biological evaluation of novel aminomethyl-piperidones based DPP-IV inhibitorsPradip Jadav, Rajesh Bahekar, Shailesh R Shah, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|October 4, 2012
Peptidomimetics as potent and selective PTP1B inhibitorsDipam Patel, Mukul Jain, Shailesh R Shah, et al.
Bioorganic & Medicinal Chemistry Letters|April 17, 2012
Long-acting peptidomimetics based DPP-IV inhibitorsPradip Jadav, Rajesh Bahekar, Shailesh R Shah, et al.
Bioorganic & Medicinal Chemistry Letters|December 23, 2011
Discovery of potent, selective and orally bioavailable triaryl-sulfonamide based PTP1B inhibitorsDipam Patel, Mukul Jain, Shailesh R Shah, et al.
ACS Medicinal Chemistry Letters|January 19, 2023
In the Quest for Potent and Selective Malic Enzyme 3 Inhibitors for the Treatment of Pancreatic Ductal AdenocarcinomaGaurav Sheth, Shailesh R Shah, Prabal Sengupta, et al.
Bioorganic & Medicinal Chemistry|January 11, 2011
Effect of structurally constrained oxime-ether linker on PPAR subtype selectivity: Discovery of a novel and potent series of PPAR-pan agonistsPankaj Makadia, Shailesh R Shah, Harikishore Pingali, et al.
Chemmedchem|September 14, 2025
Strategic Design and Development of Indole-Based Compounds as Potent Malic Enzyme 3 Inhibitors for Pancreatic Tumor TherapyGaurav Sheth, Shailesh R Shah, Prabal Sengupta, et al.
Bioorganic & Medicinal Chemistry|February 21, 2021
Discovery of a potent G-protein-coupled receptor 119 agonist for the treatment of type 2 diabetesSuresh Pola, Shailesh R Shah, Harikishore Pingali, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2011
Modulation of PPAR subtype selectivity. Part 2: Transforming PPARα/γ dual agonist into α selective PPAR agonist through bioisosteric modificationPandurang Zaware, Shailesh R Shah, Harikishore Pingali, et al.
Pageof 1